Slowing progression of chronic allograft nephropathy by conversion from cyclosporin A to tacrolimus

Journal of Central South University (Medical Sciences)

Volumn 32, Issue 1, 2007, Pages 59-62

  Peng, Long Kai ^a   Xie, Xu Biao ^a   Peng, Feng Hua ^a   Wang, Yu ^a   Jiang, Yi ^a   Lan, Gong Bin ^a   Fang, Chun Hua ^a   Nie, Man Hua ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Cyclosporine; Kidney transplantation; Nephrosis; Tacrolimus; Transplants

Indexed keywords

CHOLESTEROL; CREATININE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; LOW DENSITY LIPOPROTEIN; TACROLIMUS; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GRAFT REJECTION; HUMAN; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; AGED; CHOLESTEROL; CREATININE; CYCLOSPORINE; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; TACROLIMUS; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 33947600548     PISSN: 16727347     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Meier M, Nitschke M, Weidtmann B, et al. Slowing the progression of chronic allograft nephropathy by conversion from cyclosporine to tacrolimus: a randomized controlled trial [J]. Transplantation, 2006,81(7):1035-1040.
2. Banasik M, Klinger M. Chronic allograft nephropathy-immunologic and nonimmunologic factors [J]. Ann Transplant, 2006,11(1):7-10.
3. Ferraresso M, Ghio L, Edefonti A, et al. Conversion from cyclosporine to tacrolimus in pediatric kidney transplant recipients [J]. Pediatr Nephrol, 2002,17(8):664-667.
4. Cheung C Y, Wang K M, Chan H W, et al. Paired kidney analysis of tacrolimus and cyclosporine microemulsion-based therapy in Chinese cadaveric renal transplant recipients [J]. Transpl Int, 2006,19(8):657-666.
5. Waid T. CRAF Study Group. Tacrolimus as secondary intervention vs. cyclosporine continuation in patients at risk for chronic renal allograft failure [J]. Clin Transplant, 2005,19 (5):573-580.
6. Margreiter R, Pohanka E, Sparacino V, et al. Open prospective multicenter study of conversion to tacrolimus therapy in renal transplant patients experiencing ciclosporin-related side-effects [J]. Transpl Int, 2005,18(7):816-823.
7. Anglicheau D, Pallet N, Rabant M, et al. Role of P-glycoprotein in cyclosporine cytotoxicity in the cyclosporine-sirolimus interaction [J]. Kidney Int, 2006,70(6):1019-1025.
8. Ring P, Maode L, Li F, et al. Camparison of expression of TGF-beta 1, its receptors TGFbeta 1 R- and TGFbeta 1 R- in rat kidneys during chronic nephropathy induced by cyclosporine and tacrolimus [J]. Transplant Proc, 2006,38(7):2180-2182.
9. 1 in allograft and long-term renal function [J]. J Cent South Univ (Med Sci), 2004,29(6):700-703.
10. Kang C M, Kim G H, Lee CH, et al. Analysis of allograft biopsy specimens in renal transplants with proteinuria: is protein-uria a culprit of graft loss? [J]. Transplant Proc, 2005,37 (2):984-986.
11. Kramer B K, Montagnino G, Del Castillo D, et al. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results [J]. Nephrol Dial Transplant, 2005,20(50):968-973.